As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...
COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...